The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers

被引:10
|
作者
Benko, Tamas [1 ]
Gallinat, Anja [1 ]
Minor, Thomas [1 ]
Saner, Fuat H. [1 ]
Sotiropoulos, Georgios C. [1 ]
Paul, Andreas [1 ]
Hoyer, Dieter P. [1 ]
机构
[1] Univ Essen Duisburg, Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany
关键词
extended criteria donor; liver graft dysfunction; postoperative Model for End stage Liver Disease; risk assessment; EARLY ALLOGRAFT DYSFUNCTION; SINGLE-CENTER EXPERIENCE; PRIMARY NONFUNCTION; GRAFT FUNCTION; MELD; RETRANSPLANTATION; PRESERVATION; DEFINITION; ALLOCATION; RECIPIENTS;
D O I
10.1097/MEG.0000000000000851
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Recently, the postoperative Model for End stage Liver Disease score (POPMELD) was suggested as a definition of postoperative graft dysfunction and a predictor of outcome after liver transplantation (LT). Aim The aim of the present study was to validate this concept in the context of extended criteria donor (ECD) organs. Patients and methods Single-center prospectively collected data (OPAL study/01/11-12/13) of 116 ECD LTs were utilized. For each recipient, the Model for End stage Liver Disease (MELD) score was calculated for 7 postoperative days (PODs). The ability of international normalized ratio, bilirubin, aspartate aminotransferase, Donor Risk Index, a recent definition of early allograft dysfunction, and the POPMELD was compared to predict 90-day graft loss. Predictive abilities were compared by receiver operating characteristic curves, sensitivity and specificity, and positive and negative predictive values. Results The median Donor Risk Index was 1.8. In all, 60.3% of recipients were men [ median age of 54 (23-68) years]. The median POD1-7 peak-aspartate aminotransferase value was 1052 (194-17 577) U/l. The rate of early allograft dysfunction was 22.4%. The 90-day graft survival was 89.7%. Out of possible predictors of the 90-day graft loss MELD on POD5 was the best predictor of outcome (area under the curve = 0.84). A MELD score of 16 or more on POD5 predicted the 90-day graft loss with a specificity of 80.8%, a sensitivity of 81.8%, and a positive and negative predictive value of 31 and 97.7%. Conclusion A MELD score of 16 or more on POD5 is an excellent predictor of outcome in ECD donor LT. Routine evaluation of POPMELD scores might support clinical decision-making and should be reported routinely in clinical trials. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:716 / 722
页数:7
相关论文
共 50 条
  • [41] Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area
    Chok, Kenneth S. H.
    Fung, James Y. Y.
    Chan, Albert C. Y.
    Dai, Wing Chiu
    Sharr, William W.
    Cheung, Tan To
    Chan, See Ching
    Lo, Chung Mau
    ANNALS OF SURGERY, 2017, 265 (01) : 173 - 177
  • [42] Mortality scoring systems for liver transplant recipients: before and after model for end-stage liver disease score
    Chung, Yang-Hoon
    Jung, Jaewoong
    Kim, Sang Hyun
    ANESTHESIA AND PAIN MEDICINE, 2023, 18 (01): : 21 - 28
  • [43] Multiplication product of Model for End-stage Liver Disease and Donor Risk Index as predictive models of survival after liver transplantation
    Khalaileh, Abed
    Khoury, Tawfik
    Harkrosh, Subhi
    Nowotny, Yakob
    Massarwa, Mohamad
    Safadi, Rifaat
    Mor, Eytan
    Nakache, Richard
    Abu Gazala, Samir
    Merhav, Hadar
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (09) : 1116 - 1120
  • [44] Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry
    Ling, Qi
    Dai, Haojiang
    Zhuang, Runzhou
    Shen, Tian
    Wang, Weilin
    Xu, Xiao
    Zheng, Shusen
    SCIENTIFIC REPORTS, 2017, 7
  • [45] The MELD score predicts the short-term and overall survival after liver transplantation in patients with primary sclerosing cholangitis or autoimmune liver diseases
    Hoffmann, Katrin
    Hinz, Ulf
    Hillebrand, Norbert
    Ganten, Tom
    Gotthardt, Daniel
    Longerich, Thomas
    Schirmacher, Peter
    Schemmer, Peter
    LANGENBECKS ARCHIVES OF SURGERY, 2014, 399 (08) : 1001 - 1009
  • [46] The utility of early post-liver transplantation model for end-stage liver disease score in prediction of long-term mortality
    Dashti, Habibollah
    Ebrahimi, Amirpasha
    Khorasani, Niloofar Razavi
    Moazzami, Bobak
    Khojasteh, Fatemeh
    Shabanan, Sedighe Hosseini
    Jafarian, Ali
    ANNALS OF GASTROENTEROLOGY, 2019, 32 (06): : 633 - 641
  • [47] Combined Effects of Recipient Age and Model for End-Stage Liver Disease Score on Liver Transplantation Outcomes
    Sharpton, Suzanne R.
    Feng, Sandy
    Hameed, Bilal
    Yao, Francis
    Lai, Jennifer C.
    TRANSPLANTATION, 2014, 98 (05) : 557 - 562
  • [48] Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients
    de Camargo Aranzana, Elisa Maria
    Coppini, Adriana Zuolo
    Ribeiro, Mauricio Alves
    Bosco Massarollo, Paulo Celso
    Szutan, Luiz Arnaldo
    Ferreira, Fabio Goncalves
    CLINICS, 2015, 70 (06) : 413 - 418
  • [49] Survival Before and After Model for End-stage Liver Disease Score Introduction on the Brazilian Liver Transplant Waiting List
    Castro, R. S.
    Deisanti, D.
    Seva-Pereira, T.
    Almeida, J. R. S.
    Yamanaka, A.
    Boin, I. F. S. F.
    Soares, E. C.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (02) : 412 - 416
  • [50] COMPARING PREDICTIVE MODELS OF SHORT-TERM MORTALITY AFTER LIVING DONOR LIVER TRANSPLANTATION DUE TO ACUTE LIVER FAILURE
    Chung, H. S.
    Choi, J. H.
    Lee, J.
    Park, C. S.
    ANESTHESIA AND ANALGESIA, 2016, 123 : 132 - 132